Operating Expenses Summary of Vivesto AB

Vivesto AB's latest annual operating expenses in 2022 was 355.71 Million SEK , up 213.16% from previous year.
Vivesto AB's latest quarterly operating expenses in 2023 Q2 was 28.86 Million SEK , up 34.04% from previous quarter.
Vivesto AB reported a annual operating expenses of 113.59 Million SEK in annual operating expenses 2021, down -53.87% from previous year.
Vivesto AB reported a annual operating expenses of 246.25 Million SEK in annual operating expenses 2020, down 0.0% from previous year.
Vivesto AB reported a quarterly operating expenses of 28.86 Million SEK for 2023 Q2, up 34.04% from previous quarter.
Vivesto AB reported a quarterly operating expenses of 71.5 Million SEK for 2022 Q3, up 100.02% from previous quarter.

Annual Operating Expenses Chart of Vivesto AB (2022 - 2004)

Historical Annual Operating Expenses of Vivesto AB (2022 - 2004)

Year	Operating Expenses	Operating Expenses Growth
2022	355.71 Million SEK	213.16%
2021	113.59 Million SEK	-53.87%
2020	246.25 Million SEK	0.0%
2019	246.25 Million SEK	95.56%
2018	125.92 Million SEK	12.79%
2017	111.64 Million SEK	-22.19%
2016	143.48 Million SEK	-10.64%
2015	160.56 Million SEK	37.12%
2014	117.09 Million SEK	-6.34%
2013	125.03 Million SEK	11.23%
2012	112.4 Million SEK	-6.0%
2011	119.58 Million SEK	-11.02%
2010	134.38 Million SEK	25.01%
2009	107.5 Million SEK	5.36%
2008	102.03 Million SEK	103.85%
2007	50.05 Million SEK	31.63%
2006	38.02 Million SEK	62.83%
2005	23.35 Million SEK	94.38%
2004	12.01 Million SEK	0.0%

Year	Operating Expenses	Operating Expenses Growth
2023 Q1	21.53 Million SEK	-90.33%
2023 Q2	28.86 Million SEK	34.04%
2022 Q3	71.5 Million SEK	100.02%
2022 FY	355.71 Million SEK	213.16%
2022 Q1	27.69 Million SEK	388.38%
2022 Q2	35.74 Million SEK	29.09%
2022 Q4	222.61 Million SEK	211.35%
2021 Q1	40.86 Million SEK	113.52%
2021 Q4	5.67 Million SEK	-83.16%
2021 Q2	37.81 Million SEK	-7.45%
2021 Q3	33.67 Million SEK	-10.94%
2021 FY	113.59 Million SEK	-53.87%
2020 Q1	97.07 Million SEK	66.92%
2020 Q2	50.77 Million SEK	-47.7%
2020 Q3	70.21 Million SEK	38.3%
2020 Q4	19.13 Million SEK	-72.75%
2020 FY	246.25 Million SEK	0.0%
2019 Q1	43.2 Million SEK	51.7%
2019 Q4	58.15 Million SEK	10.06%
2019 FY	246.25 Million SEK	95.56%
2019 Q3	52.83 Million SEK	38.36%
2019 Q2	38.18 Million SEK	-11.61%
2018 Q2	27.94 Million SEK	-4.29%
2018 FY	125.92 Million SEK	12.79%
2018 Q4	28.48 Million SEK	8.34%
2018 Q1	29.19 Million SEK	7.51%
2018 Q3	26.29 Million SEK	-5.93%
2017 Q2	30.3 Million SEK	-13.61%
2017 Q4	27.16 Million SEK	8.74%
2017 FY	111.64 Million SEK	-22.19%
2017 Q3	24.97 Million SEK	-17.59%
2017 Q1	35.08 Million SEK	-8.46%
2016 FY	143.48 Million SEK	-10.64%
2016 Q1	35.22 Million SEK	-11.94%
2016 Q4	38.32 Million SEK	7.32%
2016 Q3	35.71 Million SEK	4.5%
2016 Q2	34.17 Million SEK	-3.0%
2015 Q1	30.26 Million SEK	14.52%
2015 Q4	40 Million SEK	-7.4%
2015 Q2	42.13 Million SEK	39.23%
2015 Q3	43.2 Million SEK	2.53%
2015 FY	160.56 Million SEK	37.12%
2014 Q2	31.59 Million SEK	-27.82%
2014 Q3	28.81 Million SEK	-8.81%
2014 Q4	26.42 Million SEK	-8.28%
2014 Q1	43.77 Million SEK	24.53%
2014 FY	117.09 Million SEK	-6.34%
2013 Q4	35.15 Million SEK	50.38%
2013 Q3	23.37 Million SEK	2.86%
2013 Q2	22.72 Million SEK	-32.79%
2013 Q1	33.81 Million SEK	40.83%
2013 FY	125.03 Million SEK	11.23%
2012 Q3	28.29 Million SEK	7.34%
2012 Q4	24 Million SEK	-15.14%
2012 FY	112.4 Million SEK	-6.0%
2012 Q1	135.01 Million SEK	7052.37%
2012 Q2	26.35 Million SEK	-80.48%
2011 Q4	-1.94 Million SEK	-168.16%
2011 FY	119.58 Million SEK	-11.02%
2011 Q1	35.4 Million SEK	-12.87%
2011 Q2	32.69 Million SEK	-7.67%
2011 Q3	2.84 Million SEK	-91.28%
2010 Q2	28.61 Million SEK	8.14%
2010 Q3	29.73 Million SEK	3.91%
2010 Q4	40.63 Million SEK	36.69%
2010 FY	134.38 Million SEK	25.01%
2010 Q1	26.45 Million SEK	30.76%
2009 Q4	20.23 Million SEK	-23.13%
2009 Q2	34.49 Million SEK	0.0%
2009 Q3	26.32 Million SEK	-23.69%
2009 FY	107.5 Million SEK	5.36%
2008 FY	102.03 Million SEK	103.85%
2007 FY	50.05 Million SEK	31.63%
2006 FY	38.02 Million SEK	62.83%
2005 FY	23.35 Million SEK	94.38%
2004 FY	12.01 Million SEK	0.0%

Peer Operating Expenses Comparison of Vivesto AB

Name	Operating Expenses	Operating Expenses Difference
AcuCort AB	13.24 Million SEK	-2584.867%
AlzeCure Pharma AB (publ)	38.26 Million SEK	-829.69%
BioGaia AB (publ)	507.08 Million SEK	29.851%
Enzymatica AB (publ)	79.92 Million SEK	-345.065%
Enorama Pharma AB (publ)	38.22 Million SEK	-830.566%
Gabather AB (publ)	9.47 Million SEK	-3654.676%
Klaria Pharma Holding AB (publ.)	14.88 Million SEK	-2289.936%
Moberg Pharma AB (publ)	27.46 Million SEK	-1195.263%
Nanexa AB (publ)	135.78 Million SEK	-161.977%
Newbury Pharmaceuticals AB (publ)	30.11 Million SEK	-1081.356%
ODI Pharma AB	-5.00 SEK	7114360100.0%
Orexo AB (publ)	659.4 Million SEK	46.054%
Probi AB (publ)	208.93 Million SEK	-70.255%
Swedencare AB (publ)	1.12 Billion SEK	68.459%
Swedish Orphan Biovitrum AB (publ)	9.39 Billion SEK	96.215%
Toleranzia AB	6.97 Million SEK	-5002.094%

Global Stocks Search

Vivesto AB (VIVE.ST)

Operating Expenses Summary of Vivesto AB

Annual Operating Expenses Chart of Vivesto AB (2022 - 2004)

Historical Annual Operating Expenses of Vivesto AB (2022 - 2004)

Peer Operating Expenses Comparison of Vivesto AB